Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.23 Billion CNY | -11.8% |
| 2022 | 2.48 Billion CNY | 9.86% |
| 2021 | 2.26 Billion CNY | 19.79% |
| 2020 | 1.89 Billion CNY | -46.07% |
| 2019 | 3.5 Billion CNY | -5.45% |
| 2018 | 3.7 Billion CNY | 10.08% |
| 2017 | 3.36 Billion CNY | 16.82% |
| 2016 | 2.88 Billion CNY | 12.4% |
| 2015 | 2.56 Billion CNY | 21.14% |
| 2014 | 2.11 Billion CNY | 20.13% |
| 2013 | 1.76 Billion CNY | 29.29% |
| 2012 | 1.36 Billion CNY | 49.01% |
| 2011 | 915.02 Million CNY | 23.29% |
| 2010 | 742.17 Million CNY | 56.85% |
| 2009 | 473.18 Million CNY | 76.69% |
| 2008 | 267.8 Million CNY | 63.73% |
| 2007 | 163.56 Million CNY | 70.3% |
| 2006 | 96.04 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 709.94 Million CNY | 10.17% |
| 2024 Q2 | 644.43 Million CNY | -17.33% |
| 2024 Q1 | 779.52 Million CNY | 28.17% |
| 2023 Q4 | 608.2 Million CNY | 19.07% |
| 2023 Q2 | 531.4 Million CNY | -15.6% |
| 2023 Q1 | 629.62 Million CNY | 5.22% |
| 2023 Q3 | 510.81 Million CNY | -3.87% |
| 2023 FY | 2.19 Billion CNY | -11.8% |
| 2022 Q1 | 702.06 Million CNY | 10.07% |
| 2022 Q4 | 598.39 Million CNY | -6.46% |
| 2022 Q3 | 639.69 Million CNY | 16.68% |
| 2022 FY | 2.48 Billion CNY | 9.86% |
| 2022 Q2 | 548.24 Million CNY | -21.91% |
| 2021 Q2 | 454.51 Million CNY | -17.51% |
| 2021 Q1 | 551 Million CNY | 34.02% |
| 2021 Q3 | 621.73 Million CNY | 36.79% |
| 2021 Q4 | 637.86 Million CNY | 2.59% |
| 2021 FY | 2.26 Billion CNY | 19.79% |
| 2020 Q3 | 440.81 Million CNY | 11.3% |
| 2020 Q4 | 411.14 Million CNY | -6.73% |
| 2020 FY | 1.89 Billion CNY | -46.07% |
| 2020 Q1 | 642.83 Million CNY | -6.68% |
| 2020 Q2 | 396.07 Million CNY | -38.39% |
| 2019 Q2 | 927.18 Million CNY | -1.89% |
| 2019 FY | 3.5 Billion CNY | -5.45% |
| 2019 Q1 | 945.04 Million CNY | 10.56% |
| 2019 Q3 | 944.99 Million CNY | 1.92% |
| 2019 Q4 | 688.87 Million CNY | -27.1% |
| 2018 Q2 | 904.76 Million CNY | -1.13% |
| 2018 Q4 | 854.79 Million CNY | -17.29% |
| 2018 FY | 3.7 Billion CNY | 10.08% |
| 2018 Q1 | 915.13 Million CNY | 5.04% |
| 2018 Q3 | 1.03 Billion CNY | 14.23% |
| 2017 Q3 | 881.82 Million CNY | 4.55% |
| 2017 Q2 | 843.43 Million CNY | 9.22% |
| 2017 FY | 3.36 Billion CNY | 16.82% |
| 2017 Q1 | 772.23 Million CNY | -1.01% |
| 2017 Q4 | 871.22 Million CNY | -1.2% |
| 2016 Q2 | 710.45 Million CNY | 1.64% |
| 2016 FY | 2.88 Billion CNY | 12.4% |
| 2016 Q4 | 780.13 Million CNY | 12.4% |
| 2016 Q1 | 698.96 Million CNY | 4.56% |
| 2016 Q3 | 694.06 Million CNY | -2.31% |
| 2015 Q2 | 625.21 Million CNY | 3.04% |
| 2015 FY | 2.56 Billion CNY | 21.14% |
| 2015 Q4 | 668.49 Million CNY | 0.54% |
| 2015 Q3 | 664.92 Million CNY | 6.35% |
| 2015 Q1 | 606.77 Million CNY | 1.66% |
| 2014 FY | 2.11 Billion CNY | 20.13% |
| 2014 Q4 | 596.88 Million CNY | 14.33% |
| 2014 Q1 | 505.15 Million CNY | 3.29% |
| 2014 Q3 | 522.06 Million CNY | 5.75% |
| 2014 Q2 | 493.68 Million CNY | -2.27% |
| 2013 Q2 | 420.27 Million CNY | 2.34% |
| 2013 FY | 1.76 Billion CNY | 29.29% |
| 2013 Q4 | 489.05 Million CNY | 10.43% |
| 2013 Q3 | 442.87 Million CNY | 5.38% |
| 2013 Q1 | 410.66 Million CNY | 0.13% |
| 2012 Q1 | 278.21 Million CNY | 4.72% |
| 2012 FY | 1.36 Billion CNY | 49.01% |
| 2012 Q2 | 300.66 Million CNY | 8.07% |
| 2012 Q3 | 374.44 Million CNY | 24.54% |
| 2012 Q4 | 410.13 Million CNY | 9.53% |
| 2011 Q2 | 214.34 Million CNY | 2.14% |
| 2011 Q1 | 209.85 Million CNY | 4.17% |
| 2011 FY | 915.02 Million CNY | 23.29% |
| 2011 Q4 | 265.67 Million CNY | 18.0% |
| 2011 Q3 | 225.14 Million CNY | 5.04% |
| 2010 Q1 | 171.84 Million CNY | 3.84% |
| 2010 Q2 | 191.5 Million CNY | 11.44% |
| 2010 Q3 | 177.37 Million CNY | -7.38% |
| 2010 Q4 | 201.45 Million CNY | 13.58% |
| 2010 FY | 742.17 Million CNY | 56.85% |
| 2009 Q1 | 88.51 Million CNY | 13.85% |
| 2009 Q2 | 109.9 Million CNY | 24.17% |
| 2009 Q3 | 109.28 Million CNY | -0.57% |
| 2009 FY | 473.18 Million CNY | 76.69% |
| 2009 Q4 | 165.48 Million CNY | 51.43% |
| 2008 Q3 | 67.13 Million CNY | 0.0% |
| 2008 FY | 267.8 Million CNY | 63.73% |
| 2008 Q4 | 77.74 Million CNY | 15.82% |
| 2007 FY | 163.56 Million CNY | 70.3% |
| 2006 FY | 96.04 Million CNY | 0.0% |